Role of ADAM family in normal human epidermal keratinocytes
Role of ADAM family in normal human epidermal keratinocytes
批准号:
13670890
负责人:
SHIRAKATA Yuji
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
ADAM家族是一种跨膜蛋白,具有去整合素结构域和金属蛋白酶结构域。到目前为止,已经确定了30多个成员,尽管它们在正常人类角质形成细胞中的作用和调控还没有完全确定。为了探讨ADAM家族在角质形成细胞的增殖和分化中是否起重要作用,我们研究了其在正常人角质形成细胞中的表达。我们为19个Adam家族成员构建了Taqman探测器。在无血清条件下从正常人角质形成细胞中提取总RNA,用实时定量聚合酶链式反应检测其表达水平。角质形成细胞在增殖期表达15个ADAM家族成员,加入EGF后ADAM9表达上调。为了进一步研究ADAM在皮肤病中的作用,我们研究了ADAM在寻常型银屑病(一种增生性疾病)皮损中的表达。用热激活法从13例寻常型银屑病患者皮肤和11例正常人皮肤标本中分离表皮,提取总RNA。用实时荧光定量聚合酶链式反应检测ADAM的表达。ADAM12、21、TS3、TS4、TS5、TS6在寻常型银屑病皮损中的表达与正常皮肤无明显差异,而ADAM10、17、20、28在银屑病皮损中表达下调,ADAM30在银屑病皮损中表达上调。ADAM15在银屑病表皮中的表达显著下调。此外,ADAM19和ADAMTS7在银屑病表皮中显著上调。综上所述,我们证实正常人角质形成细胞表达超过15个ADAM家族,并且ADAM家族可能参与寻常型银屑病的发病机制。
英文摘要
ADAM family is transtmembrane protein that shares a disintegrin domain and metalloproteinase domain. To date, more than 30 members have been identified, although their role and regulation in normal human keratinocytes have not been fully determined. In order to assess whether ADAM family play an important role for keratinocyte proliferation and differentiation, we investigated their expression in normal human keratinocytes. We constructed Taqman probe for 19 ADAM family members. Total RNA was harvested from normal human keratinocytes under serum free condition, and then the expression level was determined by real time polymerase chain reaction. Keratinocyte express 15 ADAM family members at proliferating phase, and ADAM9 was upregulated by the addition of EGF. To further characterize the involvement of ADAM in skin disease, we investigated ADAM expression in lesional epidermis of psoriasis vulgaris, a hyperproliferative disorder. Epidermis was separated by heat activation from 13 skin samples from psoriasis vulgaris and 11 skin samples from normal healthy skin, and total RNA was extracted. ADAM expression was determined by real time PCR. There is no difference about ADAM12, 21, TS3, TS4, TS5 and TS6 expression between psoriasis vulgaris and normal health skin, whereas ADAM10, 17, 20 and 28 were downregulated in psoriatic epidermis, and ADAM30 was upregulated in psoriatic epidermis. ADAM15 was dramatically downregulated in psoriatic epidermis. Furthermore, ADAM19 and ADAMTS7 were significantly upregulated in psoriatic epidermis. Taking together, we demonstrated that normal human keratinocytes express more than 15 ADAM families, and ADAM family might be involved in the pathogenesis of psoriasis vulgaris.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tsuda, T., Thoyama, M., Yamasaki, K., Shirakata, Y., Yahata, Y., Tokumaru, S., Sayama, H., Hashimoto, K.: "Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro."Journal of Dermatological Science. (in press). (2003)
Tsuda, T.、Thoyama, M.、Yamasaki, K.、Shirakata, Y.、Yahata, Y.、Tokumaru, S.、Sayama, H.、Hashimoto, K.:“缺乏 TARC/CCL17 生产的证据
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sayama K, Yamasaki K, Hanakawa Y, Shirakata Y, Tokumaru S, Ijuin T, Takenawa T, Hashimoto K: "Phosphatidyl inositol 3 kinase is a key regulator of early phase differentiation in keratinocytes"Journal of Biological Chemistry. 277. 40390-40396 (2002)
Sayama K、Yamasaki K、Hanakawa Y、Shirakata Y、Tokumaru S、Ijuin T、Takenawa T、Hashimoto K:“磷脂酰肌醇 3 激酶是角质形成细胞早期分化的关键调节因子”生物化学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tohyama M, Shirakara Y, Yamasaki K, Sayama K, Hashimoto K: "Differentiated keratinocytes are responsible for TNF-alpha regulated production of macrophage inflammatory protein 3alpha/CCL20, a potent chemokine for Langerhans cells"Journal of Dermatological
Tohyama M、Shirakara Y、Yamasaki K、Sayama K、Hashimoto K:“分化的角质形成细胞负责 TNF-α 调节巨噬细胞炎症蛋白 3α/CCL20 的产生,巨噬细胞炎症蛋白 3α/CCL20 是朗格汉斯细胞的有效趋化因子”皮肤病学杂志
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sayama K, Hanakawa Y, Shirakata Y, Yamasaki K, Sawada Y, Sun L, Yamanishi K, Ichijo H, Hashimoto K: "Apoptosis signal regulating kinase 1 (ASK1) is an intracellular inducer of keratinocyte differentiation"Journal of Biological Chemistry. 276. 999-1004 (20
Sayama K、Hanakawa Y、Shirakata Y、Yamasaki K、Sawada Y、Sun L、Yanishi K、Ichijo H、Hashimoto K:“凋亡信号调节激酶 1 (ASK1) 是角质形成细胞分化的细胞内诱导剂”《生物化学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wada T, Shirakata Y, Takahashi H, Murakami S, Iizuka H, Suzuki H, Hashimoto K: "A Japanese Case of Segmental Darier's Disease Caused by Mosaicism for the ATP2A2 Mutation"British Journal of Dermatology. (In press). (2003)
Wada T、Shirakata Y、Takahashi H、Murakami S、Iizuka H、Suzuki H、Hashimoto K:“由 ATP2A2 突变嵌合体引起的节段性 Darier 病的日本病例”英国皮肤病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Analysis of membrane form of EGF family growth factors in the skin carcinogenesis using tissue-specific transgenic mice
-
批准号:21591434
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:SHIRAKATA Yuji
-
依托单位:
Analysis of HB-EGF on the pathogenesis of psoriasis using tetracycline-inducible transgenic mice system.
-
批准号:19591311
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:SHIRAKATA Yuji
-
依托单位:
Analysis of the function of TOB (transducer of Erb) on proliferation and differentiation of keratinocytes
-
批准号:15591182
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:SHIRAKATA Yuji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
慢性乙肝功能性治愈mRNA药物专利转让
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵维俊
-
依托单位:
靶向子宫内膜癌的GCNT3 mRNA聚合物纳米递送系统的构建及转化研究
-
批准号:JCZRLH202601886
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
YBX1介导的HOXA9 mRNA稳定性影响c-MYC转录在胃癌进展中的机制研究
-
批准号:2026JJ82359
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:卢太亮
-
依托单位:
TET1介导GLI3 mRNA m5C去甲基化修饰负调控ABCA1促动脉粥样硬化
-
批准号:2026JJ81712
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:颜滢
-
依托单位:
基于mRNA的可调控MSLN-IL-12-CAR T联合表达Mesothelin的溶瘤病毒协同提高对非小细胞肺癌杀伤活性的研究
-
批准号:JCZRMS202601676
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
PUS7介导PCGF5 mRNA假尿苷修饰下调DUSP2表达促进甲状腺未分化癌增殖与转移的机制研究
-
批准号:2026JJ70014
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:丁颖
-
依托单位:
基于原位凝胶-LNP复合递送系统的mRNA长效释放机制与效能研究
-
批准号:2026JJ70076
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈启明星
-
依托单位:
生物正交反应介导的高效mRNA递送策略及其靶向肿瘤免疫治疗中的应用研究
-
批准号:2026JJ50009
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张崇华
-
依托单位:
清瘟败毒饮通过YBX1/m5C介导的PKM2/LDHA mRNA稳定性下调抑制糖酵解及M1巨噬细胞极化减轻脓毒症肺损伤的机制研究
-
批准号:2026JJ82076
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗柔
-
依托单位:
α-酮戊二酸抑制NSUN2介导GATA4 mRNA m5C修饰调控血管平滑肌细胞衰老相关分泌表型及动脉粥样硬化
-
批准号:2026JJ81921
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谈春芝
-
依托单位: